Starling Oncology, Inc. (STLN) short interest & options flow
NASDAQStarling Oncology enters the final week of August with an unusual divergence: the stock has pulled back nearly 5% over the week to $6.17, yet the dominant insider in the register has spent the past three months buying every meaningful dip. The most striking feature of the current setup is the persistence of insider accumulation from the company's largest shareholder. Jorey…
- Market cap
- $369M
- Next earnings
- 11 Nov 2026
Key data as of 9 Nov 2026

STLN news and analysis
RSSNo long-form analysis yet for STLN. Pulse alerts and the live data picture are available on ORTEX.
Open STLN on ORTEX →Want the live picture for STLN?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for STLN — free to start on ORTEX.
Sign up for free →Open STLN on ORTEX